Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary artery ...

Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. A generic version of Xarelto (rivaroxaban) recently became ...

FRANKFURT (Reuters) - Bayer has initiated two new late-stage studies to widen the use of its anti-blood-clotting pill Xarelto, one of its most important new drugs. The German company, which is ...

WASHINGTON (AP) — A panel of Food and Drug Administration experts again rejected Johnson & Johnson’s bid to expand use of its blood thinner Xarelto to reduce dangerous blood clots in a new group of ...

Rivaroxaban, a direct oral anticoagulant (DOAC), demonstrated greater efficacy and similar safety compared with warfarin in patients with chronic kidney disease and atrial fibrillation. Rivaroxaban, a ...

(AP) Johnson & Johnson’s Xarelto received an expanded indication as the Food and Drug Administration on Friday approved the blood thinner both to treat and to reduce the risk of recurrence of deep ...

NEW YORK - U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday. The ...

Bayer applies for EU approval for use in stroke prevention J&J files new drug application with FDA Companies say filed response to FDA for use after surgery (Adds J&J filing for U.S. approval) ...